Profitelligence provides financial data and analytics for informational purposes only. Nothing on this platform constitutes investment advice, a recommendation, or an offer to buy or sell any securities. Past performance does not guarantee future results. Always do your own research and consult a licensed financial advisor before making investment decisions.
By continuing, you acknowledge that you have read and agree to our Terms of Service and Privacy Policy.
You're browsing as a guest. Some features like watchlists and alerts require a free account.

Illumina, Inc.
| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 08/17 | ILMN | 8-K | Illumina, Inc. Completes Issuance of $300 Million in New Notes | — | — | — |
| 08/13 | ILMN | 8-K | Illumina Enters into New $1 Billion Credit Agreement | — | — | — |
| 08/12 | ILMN | 8-K | Illumina Announces $300M Notes Issuance | — | — | — |
| 08/07 | ILMN | 8-K | Illumina Settles GRAIL Acquisition Lawsuit with Mutual Releases | — | — | — |
| 07/30 | ILMN | 8-K | Illumina Reports Q2 2026 Financial Results and Updates Guidance | — | — | — |
| 06/23 | ILMN | 8-K | Illumina Appoints Dr. Daniel Skovronsky to Board of Directors | — | — | — |
| 05/26 | ILMN | 8-K | Illumina, Inc. Announces Results of 2026 Annual Meeting of Stockholders | — | — | — |
| 04/30 | ILMN | 8-K | Illumina Announces Strong Q1 2026 Financial Results and New Share Repurchase Program | — | — | — |
| 04/02 | ILMN | 8-K | Illumina Nominates David P. King to Board of Directors | — | — | — |
| 02/05 | ILMN | 8-K | Illumina Reports Q4 and FY 2025 Financial Results | — | — | — |
| 01/30 | ILMN | 8-K | Illumina Completes Acquisition of SomaLogic to Expand Proteomics Capabilities | — | — | — |
| 01/13 | ILMN | 8-K | Illumina Announces Preliminary Financial Results for Q4 and FY 2025 | — | — | — |
| 01/08 | ILMN | 8-K | Illumina Appoints New Chief Medical Officer and Announces Departure of Chief Commercial Officer | — | — | — |
| 11/25/25 | ILMN | 8-K | Illumina Completes $500M Notes Offering | — | — | — |
| 11/12/25 | ILMN | 8-K | Illumina Announces $500 Million Notes Issuance | — | — | — |
| 10/30/25 | ILMN | 8-K | Illumina Reports Q3 2025 Financial Results and Updates Guidance | — | — | — |
| 07/31/25 | ILMN | 8-K | Illumina Reports Q2 2025 Financial Results and Provides Updated Fiscal Year Guidance | — | — | — |
| 06/23/25 | ILMN | 8-K | Illumina Announces Acquisition of SomaLogic | — | — | — |
| 05/23/25 | ILMN | 8-K | Illumina, Inc. Annual Meeting Results | — | — | — |
| 05/08/25 | ILMN | 8-K | Illumina, Inc. Announces First Quarter 2025 Financial Results | — | — | — |
| 03/25/25 | ILMN | 8-K | Illumina Appoints New Board Chair and Director, Director Resignation | — | — | — |
| 03/24/25 | ILMN | 8-K | Illumina, Inc. Announces Retirement of Chief Information Officer | — | — | — |
| 03/10/25 | ILMN | 8-K | Illumina Announces Fiscal Year 2025 Guidance and Cost Reductions Amid China Export Ban | — | — | — |
| 02/06/25 | ILMN | 8-K | Illumina Reports Q4 and FY 2024 Financial Results | — | — | — |
| 01/14/25 | ILMN | 8-K | Illumina Announces Preliminary Financial Results for Q4 and FY 2024 | — | — | — |
| 01/14/25 | ILMN | 8-K | Illumina, Inc. Announces Further Real Estate Impairment Charges | — | — | — |
| 11/04/24 | ILMN | 8-K | Illumina Reports Third Quarter 2024 Financial Results | — | — | — |
| 10/03/24 | ILMN | 8-K | Illumina Announces Departure of General Counsel and Secretary | — | — | — |
| 09/09/24 | ILMN | 8-K | Illumina, Inc. Terminates Credit Agreement and Issues New Notes | — | — | — |
| 09/05/24 | ILMN | 8-K | Illumina Announces $500 Million Note Offering | — | — | — |
| 08/06/24 | ILMN | 8-K | Illumina Announces Q2 2024 Financial Results and Lowered FY 2024 Guidance | — | — | — |
| 06/27/24 | ILMN | 8-K | Illumina, Inc. Announces $1.9 Billion Impairment Charge for GRAIL Spin-Off | — | — | — |
| 06/27/24 | ILMN | 8-K | Illumina Completes Spin-Off of GRAIL and Releases Pro Forma Financials | — | — | — |
| 06/24/24 | ILMN | 8-K | Illumina Completes GRAIL Spin-Off | — | — | — |
| 06/17/24 | ILMN | 8-K | Illumina Announces New Credit Agreement | — | — | — |
| 06/06/24 | ILMN | 8-K | Illumina Announces Spin-Off Distribution Dates for GRAIL Shares | — | — | — |
| 06/03/24 | ILMN | 8-K | Illumina Announces Spin-Off of GRAIL and Associated Costs | — | — | — |
| 05/20/24 | ILMN | 8-K | Illumina, Inc. Announces Stockholder Approvals at 2024 Annual Meeting | — | — | — |
| 05/03/24 | ILMN | 8-K | Illumina, Inc. records $75 million in impairment charges due to facility exit | — | — | — |
| 05/02/24 | ILMN | 8-K | Illumina Reports First Quarter 2024 Financial Results | — | — | — |
| 04/12/24 | ILMN | 8-K | Illumina Announces EC Approval of GRAIL Divestment Plan | — | — | — |
| 04/09/24 | ILMN | 8-K | Illumina Announces New CFO and Strategic Officer Appointments | — | — | — |
| 02/08/24 | ILMN | 8-K | Illumina Announces Q4 and FY 2023 Financial Results with Goodwill Impairment | — | — | — |
| 01/09/24 | ILMN | 8-K | Illumina Announces Preliminary Financial Results for Q4 and FY 2023 | — | — | — |
| 01/09/24 | ILMN | 8-K | Illumina, Inc. Announces Estimated Impairment Charges of $43M Related to Foster City Campus Exit | — | — | — |
| 01/04/24 | ILMN | 8-K | Illumina Appoints Interim Chief Commercial Officer Following Departure of Susan Tousi | — | — | — |
Illumina, Inc. (ILMN): 46 8-K filings summarized, the most recent on Aug 17, 2026.
On August 17, 2026, Illumina, Inc. completed the issuance of $300,000,000 aggregate principal amount of its 4.950% notes due 2029. The company intends to use the net proceeds, along with cash on hand, to repay its 4.650% notes due September 9, 2026. The new notes will accrue interest at a rate of 4.950% per annum…
Illumina, Inc. Completes Issuance of $300 Million in New NotesIllumina, Inc. has entered into a new $1 billion senior unsecured five-year revolving credit facility, replacing its existing credit agreement. The new Credit Agreement provides for a variable interest rate and includes financial and operating covenants. The new facility matures on August 13, 2031, with an option for…
Illumina Enters into New $1 Billion Credit AgreementOn August 10, 2026, Illumina, Inc. entered into an Underwriting Agreement for the issuance of $300,000,000 aggregate principal amount of its 4.950% notes due 2029. The offering is expected to close on August 17, 2026, subject to customary closing conditions. Illumina plans to use the net proceeds, together with cash…
Illumina Announces $300M Notes IssuanceIllumina, Inc. has entered into a Release Agreement to settle a lawsuit related to its acquisition of GRAIL, Inc. The lawsuit, filed by Icahn Partners LP, et al., will be dismissed with prejudice as to the plaintiffs only, without affecting other stockholders or related derivative actions. The settlement involves…
Illumina Settles GRAIL Acquisition Lawsuit with Mutual ReleasesIllumina, Inc. reported financial results for the second quarter of fiscal year 2026, showing a 9.5% increase in revenue to $1.16 billion. The company reported GAAP operating margin of 21.1% and non-GAAP operating margin of 22.5%. GAAP diluted EPS was $1.35, and non-GAAP diluted EPS was $1.31. Illumina updated its…
Illumina Reports Q2 2026 Financial Results and Updates Guidance